Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Direct Acting Antivirals”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01353248
What this trial is testing

GS 5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) in Chronic Genotype 1 Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 141
Not applicableStudy completedNCT03283176
What this trial is testing

Hematologic Profile, Vit. B12 and Folic Acid in Cirrhotics Received Sofosbuvir and Daclatasvir With or Without Ribavirin

Who this might be right for
Liver CirrhosesChronic Hepatitis cDirectly Acting Antivirals
Assiut University 50
Large-scale testing (Phase 3)Study completedNCT02399345
What this trial is testing

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Co-Administered With Sofosbuvir With and Without Ribavirin in Treatment-Naive HCV Genotype 1-Infected Adults

Who this might be right for
Chronic Hepatitis C Virus (HCV Infection Genotype 1)
AbbVie 10
Large-scale testing (Phase 3)Study completedNCT02607800
What this trial is testing

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir and Sofosbuvir/Velpatasvir in Adults With Chronic HCV Infection Who Have Not Previously Received Treatment With Direct-Acting Antiviral Therapy

Who this might be right for
Hepatitis C
Gilead Sciences 943
Testing effectiveness (Phase 2)Study completedNCT01225380
What this trial is testing

Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C Infection
Gilead Sciences 324
Not applicableStudy completedNCT03248622
What this trial is testing

Hepatitis B Reactivation During Treatment With Direct-Acting Antiviral Agents for Chronic Hepatitis C Infection

Who this might be right for
Hepatitis B
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 79
Testing effectiveness (Phase 2)Study completedNCT02356562
What this trial is testing

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Sofosbuvir and Ribavirin in Direct-Acting Antiviral Agent Treatment-Experienced Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 29
Early research (Phase 1)Study completedNCT02824315
What this trial is testing

Study to Investigate the Pharmacokinetic Interaction Between 2 Direct Acting Antiviral Agents Odalasvir and AL-335 and Between 3 Direct Acting Antiviral Agents Simeprevir, Odalasvir and AL-335 at Steady State in Healthy Japanese Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 22
Not applicableStudy completedNCT04330508
What this trial is testing

Effects of Direct-acting Antiviral Agents on HCV Cognitive Function, and Depression in HCV Related Cirrhosis: A Prospective Clinical Trial

Who this might be right for
Depression in Chronic Hepatitis C
Post Graduate Institute of Medical Education and Research, Chandigarh 385
Large-scale testing (Phase 3)Study completedNCT01979939
What this trial is testing

UNITY 1: A Study of an Investigational Treatment Regimen of Daclatasvir (DCV) + Asunaprevir (ASV) + BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) for 12 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Genotype 1 Infection in Non-cirrhotic Subjects

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 416
Large-scale testing (Phase 3)Study completedNCT02707601
What this trial is testing

Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV Treatment

Who this might be right for
HIV-1 InfectionHCV Infection
Gilead Sciences 150
Testing effectiveness (Phase 2)Study completedNCT01878799
What this trial is testing

Study of A Combination Pill With GS-7977 and GS-5885 for Hepatitis C in People With HIV

Who this might be right for
Hepatitis CHIV
National Institute of Allergy and Infectious Diseases (NIAID) 50
Not applicableUnknownNCT04039698
What this trial is testing

Monitoring of Hepatitis C Treatment Using Telemedicine - a Clinical Trial in Public Health System in Brazil

Who this might be right for
Chronic Hepatitis C
Hospital de Clinicas de Porto Alegre 144
Not applicableUnknownNCT03481036
What this trial is testing

DAA Therapy in Pediatric Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis c
Post Graduate Institute of Medical Education and Research, Chandigarh 100
Testing effectiveness (Phase 2)Study completedNCT02118012
What this trial is testing

Evaluation of Safety, Tolerability, and Antiviral Activity of Chlorcyclizine HCl in Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 24
Not applicableStudy completedNCT03343925
What this trial is testing

Direct-acting Antiviral Therapy and Reinfection Among PWID With Chronic HCV in Community-based Settings

Who this might be right for
Hepatitis C, Chronic
Kirby Institute 140
Not applicableUnknownNCT04662138
What this trial is testing

Safety and Efficacy of Different Antiviral Regimens for Hepatitis C Virus Relapse

Who this might be right for
Hepatitis CRelapseAntivirals
Alexandria University 100
Not applicableStudy completedNCT03935906
What this trial is testing

Reaching mEthadone Users Attending Community pHarmacies With HCV

Who this might be right for
Hepatitis C
University of Dundee 1,410
Not applicableStudy completedNCT02526641
What this trial is testing

Macrophages, Portal Hypertension, and Liver Function During AbbVie Treatment of Chronic Hepatitis C

Who this might be right for
Hepatitis C
University of Aarhus 16
Not applicableStudy completedNCT03348059
What this trial is testing

Anti-E1E2 (D32.10 Epitope-binding) Antibodies Status Prior Therapy Favors Direct-acting Antiviral Treatment Efficacy

Who this might be right for
Chronic Hepatitis c
Hospices Civils de Lyon 103
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation